Aevi Genomic Medicine, Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy

Other Names/Subsidiaries

  • Medgenics Medical Israel Ltd.
  • neuroFix Therapeutics, LLC
  • Medgenics Inc.
See more in Biomedtracker

Latest on Aevi Genomic Medicine, Inc.

Scrip

Cerecor Turns The LIGHT Back On As Avalo, With PRV Haul In Sight

 
• By Joseph Haas

Following its late 2019 merger with Aevi Genomic Medicine, Inc. , Cerecor Inc. is taking a new name – Avalo Therapeutics – and revising its therapeutic focus, having divested a pair of central nerv

Scrip

Asia Deal Watch: Vibegron’s Vagabond Journey Continues With Eisai Acquiring Partial Asian Rights

 
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eisai To Sell Kyorin’s OAB Agent In Fou

Scrip

Deal Watch: AstraZeneca Continues Divestments By Offloading US/Canada Seroquel Rights

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . AstraZeneca Calls On Cheplap

Scrip

Deal Watch: Aevi Options AstraZeneca Antibody For Rare Disease

 
• By Joseph Haas and Alex Shimmings

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions. Aevi Obtains Option For AstraZ